我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽

搜尋 
請輸入欲查詢之關鍵字
 
  進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> Teva Pharmaceutical Industries, Ltd.

商品編號: 9-707-441
出版日期: 2006/09/18
作者姓名:
Khanna, Tarun;Palepu, Krishna G.;Madras, Claudine
商品類別: Other
商品規格: 28p

再版日期: 2010/03/30
地域: Israel
產業: Pharmaceutical industry
個案年度: 2006 -  2006

 


商品敘述:

How do companies develop a strategy that is both low-cost and differentiated without becoming squeezed in the middle? Describes how Teva, Israel''s first and largest multinational, achieved its globally dominant position in generic pharmaceuticals, an industry that has undergone significant change over the last 20 years. Examines its strategies to defend itself against both low-cost competitors from India and other emerging markets as well as Big Pharma companies, which are adopting increasingly aggressive tactics in genetics. This case is accompanied by a Video Short that can be shown in class or included in a digital coursepack. Instructors should consider the timing of making the video available to students, as it may reveal key case details.


涵蓋領域:

Competitive advantage;Industry analysis;International business;Strategy formulation


相關資料:

, (9-708-419), 5p, by Tarun Khanna, Krishna G. Palepu;
, (7447), 0p, by Tarun Khanna, Krishna G. Palepu